What BPC-157 Is
BPC stands for Body Protection Compound. BPC-157 is a synthetic peptide — a short chain of 15 amino acids — originally derived from a protective protein found in gastric juice. It has been studied extensively in animal models for its potential healing and anti-inflammatory properties, and it has attracted significant interest in sports medicine, regenerative medicine, and longevity practices.
Important Note
BPC-157 is not FDA-approved. It is available for research purposes and used off-label in some clinical settings. We are transparent about that distinction with every patient who asks about it.
What the Research Suggests
Most of the existing evidence comes from preclinical animal studies. Human clinical data is limited, and claims that outpace that evidence should be viewed skeptically. That said, the animal research is genuinely interesting and points toward several areas worth continued investigation.
- Injury recovery: Animal studies suggest BPC-157 may promote angiogenesis and collagen synthesis, both important for tendon, ligament, and muscle repair.
- Gastrointestinal health: BPC-157 was originally studied for its role in protecting the stomach lining, with potential relevance to ulcers, inflammatory bowel conditions, and NSAID-related GI damage.
- Neuroprotection: Early preclinical evidence points toward possible roles in neural recovery following traumatic brain injury, stroke, and peripheral nerve injury.
- Joint and bone health: Some studies suggest effects on inflammation and regeneration in cartilage and bone tissue.
- Systemic anti-inflammatory effects: BPC-157 appears to influence inflammation through nitric oxide modulation, growth factor stimulation, and gene expression regulation.
Side Effects and Safety
Anecdotal and experimental reports suggest BPC-157 is generally well tolerated. Reported side effects include mild headaches or dizziness, injection site irritation, GI discomfort from low-quality oral preparations, and occasional mood or energy changes.
Safety Note
Long-term human safety data does not yet exist. This is not a reason to dismiss the compound — it is a reason to be honest about what we know and do not know.
Who Should Avoid It
- Patients with active cancer
- Patients with cardiovascular disease
- Patients with autoimmune disorders
- Patients with liver or kidney disease
- Patients with clotting issues
- Pregnant or breastfeeding patients
- Patients under age 20
Our Approach
Peptide therapy is one component of a broader regenerative and longevity toolkit. At Albano Clinic, we source only pharmaceutical-grade compounded peptides, discuss the evidence honestly, and recommend peptides only when they fit a patient's specific goals and health profile.
If you're curious whether BPC-157 or other peptides make sense for your situation, that's a conversation worth having at your next consultation.